<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00829348</url>
  </required_header>
  <id_info>
    <org_study_id>61-2005-CTIL</org_study_id>
    <nct_id>NCT00829348</nct_id>
  </id_info>
  <brief_title>Short Message Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins</brief_title>
  <official_title>Short Massages Service (SMS) Impact on Patient Compliance Receiving Long Term Lipid Lowering Therapy With Statins.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to determine whether short text massages could be used
      successfully as a compliance aid and improve clinical outcomes in long term lipid lowering
      therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Indication: Patients discharged from the Intensive Cardiac Care Unit or the Internal Medicine
      Department following acute coronary syndrome (ACS) events such as unstable angina or acute
      myocardial infarction who will be prescribed a statin for the first time for preventing
      further coronary episodes.

      Drug(s) and Dose/Regimen: Regular or aggressive Simvastatin therapy (dose will be adjusted
      according to LDL and Total Cholesterol levels). Treatment period 6 months.

      Objectives: To determine whether using SMS technology can improve compliance and hence
      clinical outcomes in patients with long-term lipid lowering therapy.

      Primary outcome: number of patients who achieve target LDL goals. Secondary outcomes:
      reductions of total cholesterol, LDL, LDL/HDL and CRP; increase of HDL; Readmissions due to
      ACS.

      Study Background/Rationale/Purpose: Long-term lipid lowering therapy is the cornerstone of
      preventing recurrent cardiac events in patients that have experienced such episodes. Numerous
      studies have demonstrated the efficacy of statins in the treatment of hyperlipidemia and
      reduction of total mortality, vascular mortality and coronary adverse events1.

      One of the main concerns affecting the success of long-term chronic drug treatments is
      patients' compliance and adherence to the prescribed regimen. Till date there is no gold
      standard system that will assure complete patient compliance.

      It has been suggested to explore the possibility of using short messages service (SMS)
      technology to improve patients' compliance 2-18. Such technology may be effective in
      targeting this problem; however, no controlled trials have been conducted to validate this
      method in long-term lipid lowering treatments. Furthermore, Israel is one of the leading
      countries in terms of expansion of the mobile phone services market, making SMS a feasible
      and effective form of communication with patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients who achieve target goals</measure>
    <time_frame>Every three months at one year period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol, LDL, HDL, TG</measure>
    <time_frame>Every three months at one year period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Dyslipidemia</condition>
  <arm_group>
    <arm_group_label>Statins, counseling</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>60 patients post ACS receiving the study medication + doctor/pharmacist explanation at discharge - control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Statins, Counselling, SMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60 patients post ACS receiving the study medication + doctor/pharmacist explanation at discharge + daily SMS reminder service (8 PM) - study group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>60 patients post ACS receiving the study medication + doctor/pharmacist explanation at discharge - control group</description>
    <arm_group_label>Statins, counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Short Message Service (SMS)</intervention_name>
    <description>60 patients post ACS receiving the study medication + doctor/pharmacist explanation at discharge + daily SMS reminder service (8 PM) - study group</description>
    <arm_group_label>Statins, Counselling, SMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients discharged from the Intensive Cardiac Care Unit or the Internal Medicine
             Department following ACS who will be prescribed a statin for the first time for
             preventing further coronary episodes.

          -  Patients in the ages of 18-80.

          -  Patients who own mobile phone and are familiar with SMS technology and are able to
             read Hebrew text.

        Exclusion Criteria:

          -  Contra indication to study medication: active liver disease or elevated liver enzymes;
             hypersensitivity to Simvastatin; pregnancy and lactation.

        Developed Myopathy/Rhabodmyalisis during study period.

          -  Developed increase in transaminases greater than 3 times the upper limit of normal.

          -  Current lipid lowering treatment (statins or other).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avraham Shotan, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hillel Yaffe medical center, Hadera, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hillel Yaffe medical center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Consoli SM, Bruckert E, Marcantoni JP, Clavel T. [Factors associated with the opinion of hypercholesterolemic patients on the duration of their treatment. Results of the FRACTION study]. Presse Med. 2002 Sep 7;31(28):1302-8. French.</citation>
    <PMID>12355991</PMID>
  </reference>
  <reference>
    <citation>Ostojic V, Cvoriscec B, Ostojic SB, Reznikoff D, Stipic-Markovic A, Tudjman Z. Improving asthma control through telemedicine: a study of short-message service. Telemed J E Health. 2005 Feb;11(1):28-35.</citation>
    <PMID>15785218</PMID>
  </reference>
  <reference>
    <citation>Anhøj J, Møldrup C. Feasibility of collecting diary data from asthma patients through mobile phones and SMS (short message service): response rate analysis and focus group evaluation from a pilot study. J Med Internet Res. 2004 Dec 2;6(4):e42.</citation>
    <PMID>15631966</PMID>
  </reference>
  <reference>
    <citation>Vilella A, Bayas JM, Diaz MT, Guinovart C, Diez C, Simó D, Muñoz A, Cerezo J. The role of mobile phones in improving vaccination rates in travelers. Prev Med. 2004 Apr;38(4):503-9.</citation>
    <PMID>15020186</PMID>
  </reference>
  <reference>
    <citation>Bos A, Hoogstraten J, Prahl-Andersen B. Failed appointments in an orthodontic clinic. Am J Orthod Dentofacial Orthop. 2005 Mar;127(3):355-7.</citation>
    <PMID>15775951</PMID>
  </reference>
  <reference>
    <citation>Kwon HS, Cho JH, Kim HS, Lee JH, Song BR, Oh JA, Han JH, Kim HS, Cha BY, Lee KW, Son HY, Kang SK, Lee WC, Yoon KH. Development of web-based diabetic patient management system using short message service (SMS). Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S133-7.</citation>
    <PMID>15563964</PMID>
  </reference>
  <reference>
    <citation>Ferrer-Roca O, Cárdenas A, Diaz-Cardama A, Pulido P. Mobile phone text messaging in the management of diabetes. J Telemed Telecare. 2004;10(5):282-5.</citation>
    <PMID>15494086</PMID>
  </reference>
  <reference>
    <citation>Power MR, Power D. Everyone here speaks TXT: deaf people using SMS in Australia and the rest of the world. J Deaf Stud Deaf Educ. 2004 Summer;9(3):333-43.</citation>
    <PMID>15304436</PMID>
  </reference>
  <reference>
    <citation>Sherry E, Colloridi B, Warnke PH. Short message service (SMS): a useful communication tool for surgeons. ANZ J Surg. 2002 May;72(5):369.</citation>
    <PMID>14696592</PMID>
  </reference>
  <reference>
    <citation>Márquez Contreras E, de la Figuera von Wichmann M, Gil Guillén V, Ylla-Catalá A, Figueras M, Balaña M, Naval J. [Effectiveness of an intervention to provide information to patients with hypertension as short text messages and reminders sent to their mobile phone (HTA-Alert)]. Aten Primaria. 2004 Nov 15;34(8):399-405. Spanish.</citation>
    <PMID>15546536</PMID>
  </reference>
  <reference>
    <citation>Neville R, Greene A, McLeod J, Tracey A, Surie J. Mobile phone text messaging can help young people manage asthma. BMJ. 2002 Sep 14;325(7364):600. Erratum in: BMJ.2008 Apr 19;336(7649) doi:10.1136/bmj.39552.645775.AD. Tracy, A [corrected to Tracey A]..</citation>
    <PMID>12228151</PMID>
  </reference>
  <reference>
    <citation>Bramley D, Riddell T, Whittaker R, Corbett T, Lin RB, Wills M, Jones M, Rodgers A. Smoking cessation using mobile phone text messaging is as effective in Maori as non-Maori. N Z Med J. 2005 Jun 3;118(1216):U1494.</citation>
    <PMID>15937529</PMID>
  </reference>
  <reference>
    <citation>Lieu TA, Capra AM, Makol J, Black SB, Shinefield HR. Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organization. Pediatrics. 1998 Apr;101(4):E3.</citation>
    <PMID>9521970</PMID>
  </reference>
  <reference>
    <citation>Obermayer JL, Riley WT, Asif O, Jean-Mary J. College smoking-cessation using cell phone text messaging. J Am Coll Health. 2004 Sep-Oct;53(2):71-8.</citation>
    <PMID>15495883</PMID>
  </reference>
  <reference>
    <citation>Dyer O. Patients will be reminded of appointments by text messages. BMJ. 2003 Jun 14;326(7402):1281.</citation>
    <PMID>12805131</PMID>
  </reference>
  <reference>
    <citation>Lauruska V, Kubilinskas E. A system for teleconsulting, communication and distance learning for people with disabilities. J Telemed Telecare. 2002;8 Suppl 2:49-50.</citation>
    <PMID>12217133</PMID>
  </reference>
  <reference>
    <citation>Ferrer-Roca O, Franco Burbano K, Cárdenas A, Pulido P, Diaz-Cardama A. Web-based diabetes control. J Telemed Telecare. 2004;10(5):277-81.</citation>
    <PMID>15494085</PMID>
  </reference>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2009</study_first_submitted>
  <study_first_submitted_qc>January 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2009</study_first_posted>
  <last_update_submitted>December 29, 2009</last_update_submitted>
  <last_update_submitted_qc>December 29, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2009</last_update_posted>
  <responsible_party>
    <name_title>Avraham Shotan, MD</name_title>
    <organization>Hillel Yaffe medical center</organization>
  </responsible_party>
  <keyword>Compliance</keyword>
  <keyword>Chronic</keyword>
  <keyword>Pharmacotherapy</keyword>
  <keyword>Statins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

